Related Experiment Video
Updated: Aug 6, 2026
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
[Surgical treatment of primary small-cell esophageal carcinoma]
1Department of Thoracic Surgery, Cancer Hospital, CAMS and PUMC, Beijing 100021, China. sunkelin88@hotmail.com
Objective:
To explore the surgical treatment of primary small-cell esophageal carcinoma (PSEC).
Methods:
We retrospectively analyzed the clinical data of 73 patients with PSEC who received surgical treatment in our hospital from 1984 to 2003.
Results:
The overall resection rate was 94.5%. The complete resection rate was 89.0% and operation mortality was 1.4%. The 1-year, 3-year, and 5-year survival were 50.7%, 13.7%, and 8.2%, respectively.
Conclusions:
PSEC is a rare malignant tumor with poor prognosis. Surgical resection is the main method for patients in stage I or II, and postoperative chemotherapy seems to be helpful. Patients in stage Ill or IV should be managed with chemotherapy and radiotherapy.
